Improving pancreatic islet transplantation for type 1 diabetes treatment
Official title: Strategies to attenuate the indirect alloimmune response in encapsulated pancreatic islet transplantation
Funded at University of Miami School of Medicine · NIH-11059189 · Data updated 2026-11-12
This study is looking at a new way to help people with type 1 diabetes by protecting transplanted insulin-producing cells from the immune system, using a special gel that keeps them safe and may reduce the need for long-term medications.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Miami School of Medicine NIH-funded |
| Lab location | 1 site (Coral Gables, United States) |
| Project start | April 1, 2023 |
| Project end | March 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $53,974 |
| NIH project number | 5F30DK136276-03 |
| Project ID | NIH-11059189 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with type 1 diabetes who are considering or are eligible for pancreatic islet transplantation.
✕Less likely to help
Patients with type 2 diabetes or those who are not candidates for islet transplantation may not benefit from this research.
What this research studies
This research focuses on enhancing the success of pancreatic islet transplantation for patients with type 1 diabetes (T1D) by developing a method to protect transplanted islets from the immune response. The approach involves encapsulating islets in a special hydrogel that prevents direct contact with the immune system, potentially reducing the need for long-term immunosuppressive drugs. The study will investigate how to minimize the immune response triggered by the body against these transplanted cells, aiming to improve the longevity and effectiveness of the transplant. By using animal models, the research seeks to understand the mechanisms involved in the immune response and how to mitigate them.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer pancreatic islet transplants for type 1 diabetes patients, potentially reducing their reliance on insulin therapy.
How similar studies have gone: Previous research has shown promise in using encapsulation techniques for islet transplantation, but this specific approach is novel and aims to address unresolved immune response issues.
Where this research is happening
-
University of Miami School of Medicine
Coral Gables, United States Active
Researchers
- Principal investigator: Li, Chris Michael — University of Miami School of Medicine
- Study coordinator: Li, Chris Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.